Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs The Coca-Cola Co K (KO) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
The Coca-Cola Co KTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs The Coca-Cola Co K — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while The Coca-Cola Co K trades at $92.53 (market cap $387.70B). The key difference: The Coca-Cola Co K is far larger — about 92.8× Indivior Pharmaceuticals Inc. Common Stock's market cap, and The Coca-Cola Co K pays a 2.35% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and The Coca-Cola Co K for 154 Days on average.

INDVKO
Market Cap
$4.18B$387.70B
Volume
1,819,74615,313,783
Sector
HealthConsumer Staples
52-Week High
$41.83$91.99
52-Week Low
$24.09$67.08
Typical Hold Time
0 Days154 Days
Enterprise Value
$4.47B$414.87B
Dividend Yield
—2.35%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

The Coca-Cola Co K

Coca-Cola (KO) trades at $91.78, up 2.22% today, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $95.75. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $0.97 exceeding expectations, and maintains robust profitability with a 28.56% net income margin. Recent news highlights institutional buying and stable demand trends, though RSI levels indicate potential near-term overbought conditions.

The stock offers a solid dividend profile with 64 consecutive years of increases, but faces risks from regional demand divergence and high valuation multiples. Upside is supported by earnings momentum and institutional accumulation, while macroeconomic pressures and elevated P/E of 27.06 pose caution. The balance between growth execution and market sentiment will drive near-term performance.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
KO
14% Buy86% Sell
Avg holding period · 154 Days

Top news

Latest headlines on both assets

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About The Coca-Cola Co K

The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.

Read more on KO →